Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment protocol for relapsed anaplastic large cell lymphoma of childhood and adolescence
2005-003321-57Phase 3Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methotrexate, cytarabine, dexamethasone, vindesine, etoposide and 11 more in anaplastic large cell lymphoma (ALCL), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Event-free survival after relapse. Started Nov 2005; status: completed.
02
Drugs
methotrexatecytarabinedexamethasonevindesineetoposide
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on 2005-003321-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003321-57.